Anterior chamber-associated immune deviation, ocular immune privilege, and orthotopic corneal allografts - PubMed (original) (raw)

Review

Anterior chamber-associated immune deviation, ocular immune privilege, and orthotopic corneal allografts

J W Streilein et al. Transplant Proc. 1999 May.

No abstract available

PubMed Disclaimer

Similar articles

• Immunological non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye.
  Streilein JW. Streilein JW. Eye (Lond). 1995;9 ( Pt 2):236-40. doi: 10.1038/eye.1995.46. Eye (Lond). 1995. PMID: 7556724 Review.
• Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.
  Sano Y, Ksander BR, Streilein JW. Sano Y, et al. Invest Ophthalmol Vis Sci. 1995 Oct;36(11):2176-85. Invest Ophthalmol Vis Sci. 1995. PMID: 7558710
• Immune privilege in the anterior chamber of the eye.
  Niederkorn JY. Niederkorn JY. Crit Rev Immunol. 2002;22(1):13-46. Crit Rev Immunol. 2002. PMID: 12186187 Review.
• Effect of Corneal Nerve Ablation on Immune Tolerance Induced by Corneal Allografts, Oral Immunization, or Anterior Chamber Injection of Antigens.
  Mo J, Neelam S, Mellon J, Brown JR, Niederkorn JY. Mo J, et al. Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):137-148. doi: 10.1167/iovs.16-20601. Invest Ophthalmol Vis Sci. 2017. PMID: 28114571 Free PMC article.
• Latanoprost does not affect immune privilege of corneal allografts.
  Wang M, Kitahara Y, Yoshida A, Hori J. Wang M, et al. Exp Eye Res. 2008 Feb;86(2):394-402. doi: 10.1016/j.exer.2007.11.012. Epub 2007 Nov 28. Exp Eye Res. 2008. PMID: 18187130

Cited by

• Topical tacrolimus for high-risk corneal transplantation: a randomized, clinical trial.
  Shimazaki J, Tomida D, Yagi-Yaguchi Y, Satake Y, Yamaguchi T. Shimazaki J, et al. BMC Ophthalmol. 2024 Jun 12;24(1):251. doi: 10.1186/s12886-024-03506-6. BMC Ophthalmol. 2024. PMID: 38867175 Free PMC article. Clinical Trial.
• Anti-CD80/86 antibodies inhibit inflammatory reaction and improve graft survival in a high-risk murine corneal transplantation rejection model.
  Zhu J, Inomata T, Nakamura M, Fujimoto K, Akasaki Y, Fujio K, Yanagawa A, Uchida K, Sung J, Negishi N, Nagino K, Okumura Y, Miura M, Shokirova H, Kuwahara M, Hirosawa K, Midorikawa-Inomata A, Eguchi A, Huang T, Yagita H, Habu S, Okumura K, Murakami A. Zhu J, et al. Sci Rep. 2022 Mar 22;12(1):4853. doi: 10.1038/s41598-022-08949-9. Sci Rep. 2022. PMID: 35318419 Free PMC article.
• Current Perspectives on Corneal Transplantation.
  Liu S, Wong YL, Walkden A. Liu S, et al. Clin Ophthalmol. 2022 Mar 4;16:631-646. doi: 10.2147/OPTH.S289359. eCollection 2022. Clin Ophthalmol. 2022. PMID: 35282172 Free PMC article. Review.
• The cornea IV immunology, infection, neovascularization, and surgery chapter 1: Corneal immunology.
  Mousa HM, Saban DR, Perez VL. Mousa HM, et al. Exp Eye Res. 2021 Apr;205:108502. doi: 10.1016/j.exer.2021.108502. Epub 2021 Feb 16. Exp Eye Res. 2021. PMID: 33607075 Free PMC article. Review.
• Novel immunotherapeutic effects of topically administered ripasudil (K-115) on corneal allograft survival.
  Inomata T, Fujimoto K, Okumura Y, Zhu J, Fujio K, Shokirova H, Miura M, Okano M, Funaki T, Sung J, Negishi N, Murakami A. Inomata T, et al. Sci Rep. 2020 Nov 13;10(1):19817. doi: 10.1038/s41598-020-76882-w. Sci Rep. 2020. PMID: 33188243 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Medical

  • MedlinePlus Health Information